During the past decade, Marienkrankenhaus Schwerte conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marienkrankenhaus Schwerte" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "German Adjuvant Breast Cancer Group" with 1 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Marienkrankenhaus Schwerte" are "Breast Cancer Stage II" (1 trials), "Breast Cancer Stage III" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Marienkrankenhaus Schwerte" in a lesser frequency.

Most popular intervention types in "Marienkrankenhaus Schwerte" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel / cyclophosphamide" (1 trials), "Palbociclib" (1 trials), "Palbociclib + endocrine therapy" (1 trials), "doxorubicin/cyclophosphamide" (1 trials) and "epirubicin/cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marienkrankenhaus Schwerte" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Marienkrankenhaus Schwerte". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Marienkrankenhaus Schwerte, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marienkrankenhaus Schwerte, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".